Stocks · Healthcare · Medical - Devices
Envoy Medical, Inc. COCH
$0.68 +2.63% Close, Oct 2, 2026 · NASDAQ · Market cap $52.3M
Expensive vs sector
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -11411.1% from -8862.6% a year earlier.
- The diluted share count rose 430.8% in a year.
- The stock is 57% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 22%
- Revenue growth, 3-year CAGRBottom 25%
- Revenue growth accelerationBottom 13%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 3%
- Gross marginBottom 4%
- Operating marginBottom 3%
- Accruals (lower is better)Top 43%
- Interest coverBottom 16%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 6%
- Free-cash-flow yieldBottom 11%
- EBITDA / enterprise valueBottom 8%
- Sales / enterprise valueBottom 7%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 29%
- 6-month returnBottom 33%
- 1-year return vs S&P 500Bottom 34%
- Distance from 52-week highBottom 13%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 40%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetTop 20%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 46%
- Maximum drawdown, 3 yearsBottom 4%
- Beta vs S&P 500 (lower is better)Top 5%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 10.4% | -6.8% | ↓ |
| Gross margin | -262.2% | -385.5% | ↓ |
| Operating margin | -8862.6% | -11411.1% | ↓ |
| FCF margin | -6967.6% | -10488.4% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -6.8% | 10.4% | ↓ | Bottom 22% |
| Gross margin | -385.5% | -262.2% | ↓ | Bottom 4% |
| Operating margin | -11411.1% | -8862.6% | ↓ | Bottom 3% |
| Net margin | -11304.8% | -9579.3% | ↓ | — |
| Free-cash-flow margin | -10488.4% | -6967.6% | ↓ | — |
| Return on invested capital | -206.4% | — | Bottom 3% | |
| Revenue growth, 3-year CAGR | 0.6% | — | Bottom 25% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -7.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 287.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +11.5 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -50.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -70.78%
- Shareholder yield
- -70.78%
- Share count change, 1 year
- +430.8%
- Share count change, 3-year CAGR
- +74.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -1.0%
- Average 2-day reaction, last 8
- -0.2%
- Positive 20 days after report
- 6 of 8
Analysts
- Consensus price target
- $2.00
- Target vs current price
- +195.0%
- Analysts with a rating
- 3
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | +12.5% | +5.0% | +19.2% | +5.8% | — |
| May 11, 2026 | +21.4% | -0.2% | +0.2% | +2.1% | +6.0% |
| Mar 23, 2026 | -8.3% | -3.4% | -15.9% | -10.1% | -16.5% |
| Nov 10, 2025 | -29.6% | -0.3% | -4.9% | +18.7% | -24.5% |
| Jul 31, 2025 | -10.3% | -6.4% | -3.2% | -25.0% | -47.3% |
| May 1, 2025 | +17.1% | -2.8% | +7.0% | +12.7% | +7.7% |
| Mar 28, 2025 | -36.4% | -2.2% | -0.7% | +6.5% | +2.2% |
| Nov 14, 2024 | -37.0% | +8.7% | +9.7% | +6.1% | -28.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.07 | -$0.08 | +12.5% | $51,000 |
| May 11, 2026 | -$0.11 | -$0.14 | +21.4% | $39,000 |
| Mar 23, 2026 | -$0.26 | -$0.24 | -8.3% | $100,000 |
| Nov 10, 2025 | -$0.35 | -$0.27 | -29.6% | $42,000 |
| Jul 31, 2025 | -$0.32 | -$0.29 | -10.3% | $78,000 |
| May 1, 2025 | -$0.29 | -$0.35 | +17.1% | $46,000 |
| Mar 28, 2025 | -$0.45 | -$0.33 | -36.4% | $42,000 |
| Nov 14, 2024 | -$0.37 | -$0.27 | -37.0% | $56,000 |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 161.69× | — | — | Bottom 7% |
| Free-cash-flow yield | -41.48% | — | — | Bottom 11% |
| Earnings yield | -99.22% | — | — | Bottom 6% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -0.6%
- 200-day average slope (20 days)
- -1.2%
- Distance from 50-day average
- -4.5%
- Distance from 200-day average
- -2.1%
- RSI (14)
- 43.9
- Relative volume
- 2.72×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 58.2%
- Volatility vs own 5-year history
- 41th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.19
- Correlation with S&P 500
- 0.04
- Current drawdown from 1-year high
- -57.4%
- Maximum drawdown, 3 years
- -96.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 21, 2023 | Feb 10, 2026 | -96.3% | 598 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $52.3M
- EPS, diluted (TTM)
- -$0.67
- Revenue (TTM)
- $207,000
- 52-week range
- $0.36 – $1.89
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $310,000 | $237,000 | $316,000 | $225,000 | $241,000 |
| Gross profit | -$459,000 | -$261,000 | -$473,000 | -$517,000 | -$633,000 |
| Operating income | -$6.9M | -$8.7M | -$18.4M | -$19.3M | -$22.3M |
| Net income | -$8.7M | -$15.9M | -$29.9M | -$20.8M | -$23.8M |
| EPS (diluted) | -$1.05 | -$1.57 | -$2.54 | -$1.49 | -$1.23 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $56,000 | $42,000 | $46,000 | $78,000 | $42,000 | $75,000 | $39,000 | $51,000 |
| Net income | -$6.0M | -$4.6M | -$5.0M | -$5.7M | -$6.5M | -$6.6M | -$4.4M | -$6.0M |
| EPS (diluted) | -$0.37 | -$0.36 | -$0.29 | -$0.32 | -$0.35 | -$0.17 | -$0.08 | -$0.07 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$6.9M | -$8.8M | -$17.1M | -$17.9M | -$18.2M |
| Capital expenditure | -$125,000 | -$218,000 | -$153,000 | -$980,000 | -$179,000 |
| Free cash flow | -$7.1M | -$9.0M | -$17.2M | -$18.9M | -$18.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $58,000 | $92,000 | $109,000 | $3.6M | $9.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $19.7M
- Total assets
- $23.9M
- Total liabilities
- $20.6M
- Total debt
- $810,000
- Net debt
- -$18.9M
- Shareholders’ equity
- $3.3M
As of Jun 30, 2026 (filed Aug 10, 2026).
Short interest
- Shares sold short
- 529,130
- Days to cover
- 10.79
- Change vs previous report
- -12.7%
FINRA short interest, settlement date Sep 15, 2026.